GENEVA, SWITZERLAND--(Marketwire - March 17, 2008) - Addex Pharmaceuticals (SWX: ADXN) announced today that on March 13, 2008, The Swiss Helvetia Fund, Inc. 1270 Avenue of the Americas, Suite 400, New York, NY 10020, U.S.A., has informed of exceeding the threshold of 3% in the shareholding of Addex Pharmaceuticals Ltd., holding a total of 288,360 registered shares, corresponding to 4.92% of the voting rights.
